Literature DB >> 36104413

Does prostate-cancer treatment place a strain on the heart?

Charlie Schmidt.   

Abstract

Entities:  

Keywords:  Cancer; Health care; Therapeutics

Mesh:

Year:  2022        PMID: 36104413     DOI: 10.1038/d41586-022-02863-w

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  3 in total

1.  Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.

Authors:  Renato D Lopes; Celestia S Higano; Susan F Slovin; Adam J Nelson; Robert Bigelow; Per S Sørensen; Chiara Melloni; Shaun G Goodman; Christopher P Evans; Jan Nilsson; Deepak L Bhatt; Noel W Clarke; Tine K Olesen; Belinda T Doyle-Olsen; Henriette Kristensen; Lauren Arney; Matthew T Roe; John H Alexander
Journal:  Circulation       Date:  2021-08-30       Impact factor: 39.918

2.  Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.

Authors:  Neal D Shore; Fred Saad; Michael S Cookson; Daniel J George; Daniel R Saltzstein; Ronald Tutrone; Hideyuki Akaza; Alberto Bossi; David F van Veenhuyzen; Bryan Selby; Xiaolin Fan; Vicky Kang; Jackie Walling; Bertrand Tombal
Journal:  N Engl J Med       Date:  2020-05-29       Impact factor: 91.245

3.  Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.

Authors:  Joshua D Wallach; Yihong Deng; Rozalina G McCoy; Sanket S Dhruva; Jeph Herrin; Alyssa Berkowitz; Eric C Polley; Kenneth Quinto; Charu Gandotra; William Crown; Peter Noseworthy; Xiaoxi Yao; Nilay D Shah; Joseph S Ross; Timothy D Lyon
Journal:  JAMA Netw Open       Date:  2021-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.